• Medical School
  University of Missouri, 2015
• Internship
  Mercy Hospital St. Louis, 2016
• Residency
  Dermatology, University of Missouri, 2019
• Fellowship
  Complex Medical Dermatology, Brigham & Women's Hospital, 2020

Apalla Z, Freites-Martinez A, Grafanaki K, et al including Hirner J. Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process. J Eur Acad Dermatol Venereol. 2024. E-pub ahead of print. doi: 10.1111/jdv.20391.

Bang AS, Said JT, Hirner J, et al. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer. Support Care Cancer. 2024;32(6):354. doi: 10.1007/s00520-024-08551-x.

Adebiyi A, Praveen R, Hirner J, et al. Comparison of three deep learning models in accurate classification of 770 dermoscopic skin lesion images. J Am Med Inform Assoc. 2024;31;2024:46-53.

Larocca CA, Fay CJ, Hirner JP, et al. Diffuse cutaneous aphthosis due to combined targeted cancer therapies and responsive to pentoxifylline: a novel dermatologic adverse event presenting as a morphologic mimic of Degos Disease and Behcet’s Disease. JAMA Dermatol. 2023;159(10):1136-1139. doi:10.1001/jamadermatol.2023.2649

Mital R, Otto TS, Savu A, et al including Hirner J. Detection of novel therapies using a multinational, multi-institutional registry of cutaneous immune-related adverse events and management. Int J Dermatol. 2023;202;62(8):1020-1025. doi: 10.1111/ijd.16714

Hirner J. Updates in cutaneous oncology. Mo Med. 2023;120(1):53-58. PMID: 36860605

Becker NV, Bakshi S, Martin KL, et al including Hirner JP. Provider experience and satisfaction with a novel virtual team rounding program during the COVID-19 pandemic. Int J Qual Health Care. 2021;33(3):1-7. doi:10.1093/intqhc/mzab111

Becker NV, Bakshi S, Martin KL, et al including Hirner JP. Virtual team rounding: A cross-specialty inpatient care staffing program during the COVID-19 pandemic. Acad Med. 2021; 96(12):1717-21. doi: 10.1097/ACM.0000000000004208

Bui AN, Singer S, Hirner J, et al. Cutaneous connective tissue disease associated with immune checkpoint inhibitor therapy: a retrospective analysis. J Am Acad Dermatol. 2021;84(3):864-9. doi: 10.1016/j.jaad.2020.10.054

Bui AN, Hirner J, Singer S et al. De novo subacute cutaneous lupus erythematosus like eruption in the setting of PD-1 or PD-L1 inhibitor therapy: clinicopathologic correlation. Clin Exp Dermatol. 2021;46(2):328-37. doi: 10.1111/ced.14449

Hirner J, Cleary JM, Sheets A, Murphy G, LeBoeuf N. Fibroblast growth factor receptor inhibitors and nonuremic calciphylaxis. JAMA Dermatol. 2021;157(1):119-21. doi: 10.1001/jamadermatol.2020.4076

Hirner JP, O’Malley JT, LeBoeuf N. Blastic plasmacytoid dendritic cell neoplasm: the dermatologist’s perspective. Hematol Oncol Clin North America. 2020;(34)3:501-9. doi: 10.1016/j.hoc.2020.01.001

Hirner, J. Subacute cutaneous lupus erythematosus with a possible paraneoplastic association with melanoma. BMJ Case Rep. 2019;12(11):e230558. doi: 10.1136/bcr-2019-230558

Hirner J, Day M. Does use of compression stockings after DVT improve outcomes? Evidence-Based Practice. 2016;19(3):12-14. doi: 10.1097/01.EBP.0000541176.09862.1a

Hirner JP, Koopman PJ. Lupus pernio as the presenting symptom of sarcoidosis: a case report.
Missouri Family Physician. 2014;33(4):8-10.

Choma TJ, Pfeiffer FM, Swope RW, Hirner JP. Pedicle screw design and cement augmentation in osteoporotic vertebrae: effects of fenestrations and cement viscosity on fixation and extraction. Spine. 2012;37(26):1628-32. doi: 10.1097/BRS.0b013e3182740e56

Melanoma
Pigmented skin lesions
Skin cancer
Supportive oncodermatology
General dermatology